fluoxetine- fluoxetine capsules capsule
mckesson packaging services business unit of mckesson corporation - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine hydrochloride 20 mg - fluoxetine is indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to18 years [see clinical studies (14.1)]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods, should periodically be reevaluated [see dosage and administration (2.1)]. fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd) [see clinical studies (14.2)]. the effectiveness of fluoxetine in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine for extended periods, should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2)]. fluoxetine is indicated for the acute and maintenance treatment of bing
fluoxetine- fluoxetine hydrochloride capsule
a-s medication solutions - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 20 mg - fluoxetine capsules are indicated for the treatment of: - acute and maintenance treatment of major depressive disorder [see clinical studies (14.1)] . - acute and maintenance treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd) [see clinical studies (14.2)] . - acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa [see clinical studies (14.3)] . - acute treatment of panic disorder, with or without agoraphobia [see clinical studies (14.4)] . fluoxetine capsules and olanzapine in combination are indicated for the treatment of: - acute treatment of depressive episodes associated with bipolar i disorder. - treatment resistant depression (major depressive disorder in patients, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode). fluoxetine capsules monotherapy is not indicated for the treatment of depressive episodes associated with bi
fluoxetine 20mg capsules
medreich plc - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
flamingo pharma (uk) ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
noumed life sciences ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
actavis uk ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
genus pharmaceuticals ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
ivax pharmaceuticals uk ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
kent pharma (uk) ltd - fluoxetine hydrochloride - oral capsule - 20mg
fluoxetine 20mg capsules
sandoz ltd - fluoxetine hydrochloride - oral capsule - 20mg